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Hexachlorobenzene (HCB) and dichloro­
diphenyltrichloroethane (DDT) are organo­
chlorines (OCs) used in fungus and pest 
control. These OCs have demonstrated estro­
genic activity in in vitro assays and adverse 
reproductive effects in fish and wildlife 
(Tiemann 2008). Although HCB and DDT 
have been banned in the United States, HCB 
is a by­product of organic chemical produc­
tion processes and is still produced outside the 
United States [Agency for Toxic Substances 
and Disease Registry (ATSDR) 2002b]. DDT 
continues to be used abroad for the control of 
mosquito­borne diseases (van den Berg 2009).
The main source of human exposure 
to these OCs is through dietary ingestion. 
Generally, HCB and DDT are found in meat, 
fish, and milk products (Brilhante and Franco 
2006; Fontcuberta et al. 2008; Mawussi et al. 
2009; Yu et al. 2009). DDT can be found in 
higher concentrations in foods imported from 
countries still using DDT (ATSDR 2002a). 
Because of their chemical stability, bioaccu­
mulation up the food chain, and the ongoing 
production or use in some countries, HCB, 
DDT, and dichlorodiphenyldichloroethyl­
ene (DDE), the primary metabolite of DDT, 
continue to be detected in human blood 
(ATSDR 2002a), breast milk (Tsang et al. 
2011), follicular fluid (Meeker et al. 2009), 
amniotic fluid (Foster et al. 2000; Luzardo 
et al. 2009), and human umbilical cord blood 
(Jimenez Torres et al. 2006).
There are conflicting data regarding the 
effect of exposure to DDT/DDE on early 
reproductive outcomes. A recent study 
described no association between oocyte, fer­
tilization, and implantation parameters in 
women undergoing in vitro fertilization (IVF) 
and exposure to DDT (Al­Saleh et al. 2009). 
Another study found an association between 
increased time to pregnancy and self­report of 
exposure to agricultural and home pesticides 
(Harley et al. 2008). Some studies suggest an 
association of DDT/DDE with early clinically 
detected fetal loss (Longnecker et al. 2005; 
Venners et al. 2005). Other studies reported 
early pregnancy loss and early neonatal and 
childhood mortality after a widespread acciden­
tal exposure to HCB in Turkey (Jarrell et al. 
1998; Peters et al. 1982). Because of concerns 
raised by these earlier studies, we explored the 
association of serum levels of these persistent 
OCs with early reproductive failure uniquely 
observable within the context of an IVF study.
Methods
Study population. This study population is a 
nested case–control subset of patients derived 
from a prospective cohort designed to assess 
predictors of IVF outcomes. Between August 
1994 and June 2003, couples commencing 
assisted reproduction therapy were enrolled 
through three Boston, Massachusetts, area 
clinics. Couples agreeing to participate in 
this study underwent an informed consent 
process and provided written consent before 
enrollment. There were two phases of patient 
enrollment, 1994–1999 and 2000–2003, cor­
responding to initial funding and renewal 
phases. Study protocols were approved by the 
Institutional Review Board at Brigham and 
Women’s Hospital and the Human Subjects 
Committee at Harvard School of Public 
Health. Approximately 65% of couples who 
were approached agreed to participate in the 
study. Couples who required donor gametes, 
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Outcomes
Shruthi Mahalingaiah,1 Stacey A. Missmer,1,2,3 Arnab Maity,4 Paige L. Williams,5 John D. Meeker,6 
Katharine Berry,1 Shelley Ehrlich,7 Melissa J. Perry,7,8 Daniel W. Cramer,1 and Russ Hauser 2,7,9
1Department of Obstetrics, Gynecology and Reproductive Biology, Brigham and Women’s Hospital and Harvard Medical School, 
Boston, Massachusetts, USA; 2Department of Epidemiology, Harvard School of Public Health, Boston, Massachusetts, USA; 3Channing 
Laboratory, Department of Medicine, Brigham and Women’s Hospital and Harvard Medical School, Boston, Massachusetts, USA; 
4Department of Statistics, North Carolina State University, Raleigh, North Carolina, USA; 5Department of Biostatistics, Harvard School 
of Public Health, Boston, Massachusetts, USA; 6Department of Environmental Health Sciences, University of Michigan School of Public 
Health, Ann Arbor, Michigan, USA; 7Department of Environmental Health, Harvard School of Public Health, Boston, Massachusetts, 
USA; 8Department of Environmental and Occupational Health, School of Public Health and Health Services, George Washington 
University, Washington, DC, USA; 9Vincent Memorial Obstetrics and Gynecology Service, Andrology Laboratory and In Vitro Fertilization 
Unit, Massachusetts General Hospital, Boston, Massachusetts, USA
Background: Hexachlorobenzene (HCB), dichlorodiphenyltrichloroethane (DDT), and dichloro ­
diphenyldichloroethylene (DDE) are persistent chlorinated pesticides with endocrine activity that 
may adversely affect the early stages of human reproduction.
oBjective: Our goal was to determine the association of serum levels of HCB, DDT, and DDE 
with implantation failure, chemical pregnancy, and spontaneous abortion in women undergoing 
in vitro fertilization (IVF) from 1994 to 2003.
Methods: Levels of HCB and congeners of DDT and DDE were measured in serum collected 
during the follicular phase. Multivariable­adjusted statistical models accommodating multiple out­
comes and multiple cycles per woman were used to estimate the relation between serum pesticide 
levels and IVF outcomes.
results: A total of 720 women with a mean ± SD age 35.4 ± 4.2 years at enrollment contributed 
774 IVF cycles. All samples had detectable levels of HCB, DDT, and DDE, with median levels of 
0.087 ng/g serum for HCB, 1.12 ng/g serum for total DDT, and 1.04 ng/g serum for p,p´­DDE. 
Compared with the lowest quartile (Q1) of HCB, the lipid­ and multivariable­adjusted odds 
ratio (OR) for failed implantation was significantly elevated for those with higher HCB quartiles 
[Q2–Q4; adjusted ORs: for Q2, 1.71; 95% confidence interval (CI): 1.03, 2.82; for Q3, 2.30; 
95% CI: 1.39, 3.81; for Q4, 2.32; 95% CI: 1.38, 3.90] and showed a significantly increasing trend 
(p = 0.001). No statistically significant associations were observed between DDT/DDE and IVF 
outcomes or between HCB and chemical pregnancy or spontaneous abortion.
conclusions: Serum HCB concentrations were on average lower than that of the general 
U.S. population and associated with failed implantation among women undergoing IVF.
key words: assisted reproduction, dichlorodiphenyldichloroethylene, dichlorodiphenyl­
trichloroethane, hexachlorobenzene, prospective cohort. Environ Health Perspect 120:316–320 
(2012). http://dx.doi.org/10.1289/ehp.1103696 [Online 29 August 2011]
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a gestational carrier, or gamete/zygote intr­
afallopian transfer were excluded from the 
main study. Most couples underwent mul­
tiple IVF cycles (up to six), with an average of 
two cycles per couple.
Because of budget limitations, we were 
unable to measure serum OC levels on all of 
the study participants. Therefore, we devised 
our case and control selection strategy to max­
imize statistical power, selecting cases based 
on outcomes of interest. Of the 2,350 couples 
in the main study, 765 women were selected 
by the outcome of their first IVF cycle (failed 
implantation, chemical pregnancy, sponta­
neous abortion, or live birth). Because the 
number of available cases varied by failure 
type, with failed implantation being most fre­
quent, we analyzed serum HCB/DDT/DDE 
concentrations for a random sample of 200 
women with first­cycle implantation failures. 
Because chemical pregnancies and spontane­
ous abortions were less frequent, all cycles 
from the entire cohort with these outcomes 
were selected. Also included in the analysis 
were 62 repeated cycles among a subset of 46 
women, from a total of 265 cycles from 110 
women who were selected for measurement of 
DDE, DDT, and HCB in a prior analysis of 
within­woman variability in serum concentra­
tions of OC compounds from the same parent 
study (Meeker et al. 2009). A corresponding 
sample of first­cycle live births was selected 
using stratified sampling based on age cat­
egory, study center, and study phase. In total, 
765 women contributed 827 cycles.
Data abstracted from clinical records 
were infertility diagnoses, ovarian stimula­
tion protocol (down­regulation or flare), type 
and total ampules of gonadotropin, use of 
intracytoplasmic sperm injection (ICSI), day 
of embryo transfer (ET), number of embryos 
transferred, and cycle outcomes.
Only women who proceeded to undergo 
ET of one or more embryos were eligible for 
the present analysis. When at least one embryo 
was transferred but without subsequent rise of 
human chorionic gonadotropin (hCG) beyond 
5.0 mIU/mL, the cycle outcome was defined 
as a failure of implantation. A chemical preg­
nancy was defined by a post­ET hCG meas­
urement of ≥ 5.0 mIU/mL with no further 
embryonic development (gestational sac or yolk 
sac). Clinical pregnancy was determined by 
ultrasound visualization of a gestational sac or 
a fetal heartbeat. Among clinically recognized 
pregnancies, outcomes included spontaneous 
abortion (fetal demise before 20 weeks of gesta­
tion) or live birth of at least one infant. Other 
outcomes for clinically recognized pregnancy 
were ectopic pregnancy, molar pregnancy, 
and stillbirth (fetal demise at ≥ 20 gestational 
weeks) and were excluded in the present anal­
ysis because numbers were small and lacked 
power for independent investigation.
Measurement of HCB, DDT, and DDE 
in serum. Blood samples were collected from 
women during the follicular phase of their first 
IVF/ICSI cycle and subsequent cycles in a non­
fasting state immediately before hCG adminis­
tration. The serum fraction was separated for 
all blood samples by centrifugation and stored 
at –80°C. Measurement of the OC pesticides 
HCB, p,p´­DDT, p,p´­DDE, o,p´­DDT, and 
o,p´­DDE was conducted by the Organic 
Chemistry Analytical Laboratory, Harvard 
School of Public Health (Boston, MA), using 
methods described previously (Korrick et al. 
2000). Briefly, after liquid–liquid extraction 
and column chromatography, samples were 
analyzed by dual gas chromatography with 
electron capture detection, on two capillary 
columns of different polarity using two inter­
nal standards. Samples were accompanied by 
the following quality control samples: a pro­
cedural blank, matrix spike samples, and a 
laboratory control sample. Each sample was 
spiked with two surrogate compounds to mon­
itor the efficiency of the extraction procedure. 
All final results were reported after subtract­
ing the amount of the analyte measured in 
the procedural blank associated with the ana­
lytic batch. Method detection limits (MDLs) 
were determined as recommended by the U.S. 
Environmental Protection Agency (1984).
The wet­weight MDL values for HCB 
and congeners of DDT and DDE were all 
< 0.01 ng/g. The OC concentrations were 
measured at part per billion concentrations. 
The within­assay variation for all target pesti­
cides ranged from 2% to 5%. The between­
 assay variation (percent coefficient of variation) 
for all target pesticides was < 10%.
Serum total cholesterol and triglycerides 
were measured enzymatically. Total serum 
lipid content was calculated by Equation 2 of 
Phillips et al. (1989) and then used for lipid 
standardization of serum OC concentration.
Statistical analysis. Serum OC concentra­
tions in the study population of 765 women 
were grouped into quartiles (Q1–Q4). Total 
DDT was defined for this analysis as a sum 
of p,p´­DDT, o,p´­DDT, p,p´­DDE, and 
o,p´­DDE. The relation between IVF out­
comes and quartiles of HCB, p,p´­DDE, and 
total DDT was explored with multivariable 
generalized linear regression models, with data 
structured to accommodate joint models for 
multiple outcomes and multiple cycles con­
tributed per woman. Whenever a woman was 
at risk of a cycle failure because of implanta­
tion failure, chemical pregnancy, or spontane­
ous abortion in each cycle, a binary outcome 
(1 = failure, 0 = not a failure) was recorded. 
Thus, a woman provided up to three contri­
butions to risk sets for the possible outcomes 
within each IVF cycle. A logistic regression 
model was then employed for each early preg­
nancy outcome, while adjusting for covariates. 
Interaction terms between OC quartile and 
failure type were included in the model to 
allow for a distinct relation between the OC 
of interest and reproductive failure type. 
Interaction terms between age and failure type 
were also included to account for the possibil­
ity of differing age effects on the various failure 
end points. A woman­specific random­effect 
term, assumed to be Gaussian, was included to 
account for the correlation among outcomes 
from different cycles for the same woman. 
Trend tests were conducted by assigning ordi­
nal integer values to HCB, DDE, and DDT 
quartiles (0 = Q1 to 3 = Q4).
Potential confounding variables consid­
ered in our analyses were maternal age (< 35, 
35–37, 38–40, > 40 years), body mass index 
(BMI), serum lipids, smoking status (never, 
past, or current), site (of the three participating 
Boston area clinics), study phase (1994–1998 
or 1999–2003), race (Caucasian or other), pre­
vious live birth (yes/no), ampules of gonado­
tropins, protocol (down­regulation or other), 
ICSI (yes/no), number of embryos transferred, 
and primary infertility diagnosis. Primary infer­
tility diagnoses were categorized as male factor, 
ovulatory dysfunction, and other/unexplained. 
The “other/unexplained” category included 
Müllerian anomalies and uterine or tubal 
pathology. Cycles that were missing race, infer­
tility diagnosis, or previous live birth (6% of 
cycles) were assigned a missing indicator vari­
able and retained in all analyses. Cycles missing 
any other covariate information were excluded.
The serum OC concentrations were stan­
dardized by dividing by the calculated total 
serum lipid concentration. In addition, we 
also modeled IVF outcomes in relation to 
wet­weight serum levels of the specific and 
adjusted for serum lipids as a covariate in 
multivariable models, to reduce bias, as sug­
gested by Schisterman et al. (2005).
Data analysis was conducted using SAS 
software (version 9.1; SAS Institute Inc., 
Cary, NC). p­Values < 0.05 were considered 
statistically significant.
Results
Of the 827 IVF cycles evaluated, 774 (94%) 
had sufficient covariate information to be 
included in our analysis, representing 720 
(94%) of the 765 women. Among the 54 IVF 
cycles excluded, 6 were missing BMI, 13 were 
missing lipids, 2 were missing ampules of 
gonadotropins, and 32 were missing num­
ber of embryos transferred. The 720 women 
had a mean age of 35 years, were primarily 
Caucasian (90%) and current non smokers 
(94%), and had a mean BMI of 24.2 kg/m2 
(Table 1). Unexplained infertility (34%) and 
male factor (35%) accounted for most infer­
tility diagnoses; the remaining women were 
diagnosed with either tubal factor (18%) or 
ovulatory dysfunction (13%). Because of 
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the nested case–control sampling design, the 
oversampling of failure outcomes on a subset 
of women was not representative of the failure 
outcome percentages of the main study. There 
were 541 total cycle failures, of which 490 
were included in the analysis and consisted 
of implantation failure (209), chemical preg­
nancy (161), and spontaneous abortion (120).
Distributions of serum concentrations 
of HCB, DDT, and DDE are presented as 
both wet­weight and lipid­standardized con­
centrations (Table 2). No samples were below 
the limit of detection. The geometric mean 
(GM) and median concentration for HCB 
were 0.088 and 0.087 ng/g serum, respec­
tively, compared with a GM and median 
of 0.095 and 0.092 ng/g serum in the gen­
eral U.S. female population in 2003–2004 
[Centers for Disease Control and Prevention 
(CDC) 2009]. Total DDT had the highest 
concentration (median = 1.12 ng/g serum, 
range 0.02–31.8 ng/g serum). Most of the 
total DDT was from p,p´­DDE contributions, 
which accounted for > 90% of the sum of all 
measured DDT/DDE congeners. The GM and 
median p,p´­DDE concentrations were, respec­
tively, 1.09 and 1.04 ng/g serum, with a range 
of 0.007–30.6 ng/g serum, compared with a 
GM and median of 1.45 and 1.25 ng/g serum 
in the general female U.S. population (CDC 
2009). The GM and median for p,p´­DDT in 
the general female U.S. population included 
levels below the limit of detection (CDC 
2009). There was a strong correlation between 
the concentration of total DDT and p,p´­DDE 
(Spearman correlation coefficient = 0.98). Of 
the 46 women with serum from multiple cycles 
ultimately included in the final analysis, 29 
(63%) remained in the same HCB quartile 
across cycles after lipid standardization, simi­
lar to the 34 (71%) with lipid adjustment in 
the multivariable model. HCB concentrations 
between cycles were also strongly correlated 
(Spearman correlation coefficient = 0.98).
When serum lipids were adjusted as a 
covariate with other potential confounders, 
a dose–response relation between increasing 
HCB concentration quartile and odds ratios 
(ORs) for failed implantation was observed 
(Table 3). Compared with women in Q1, 
the multivariable adjusted ORs for failed 
implantation were 1.71 for women in Q2 
[95% confidence interval (CI): 1.03, 2.82], 
2.30 for women in Q3 (95% CI: 1.39, 3.81), 
and 2.32 for women in Q4 (95% CI: 1.38, 
3.90; p­value, test for linear trend = 0.001). 
When lipid­standardized HCB concentrations 
were used as the dependent variable, a statisti­
cally significant linear increase in ORs for 
implantation failure remained. Although no 
statistically significant associations were found 
between serum HCB and chemical pregnancy, 
spontaneous abortion, or early pregnancy fail­
ure, ORs for early pregnancy failure increased 
with increasing HCB quartiles. Lack of statis­
tical significance may be due to the relatively 
small numbers of chemical pregnancies and 
spontaneous abortions.
Although no statistically significant asso­
ciations were found between p,p´­DDE and 
any individual or combined early reproduc­
tive failures, the OR for any of the three early 
pregnancy failure types among cycles in Q4 
p,p´­DDE versus Q1 was 1.6 (95% CI: 0.98, 
2.63) (Table 4). The OR for Q4 total DDT, 
after lipid adjustment, and early pregnancy 
failure versus Q1 was 1.85 (95% CI: 1.13, 
3.03; p­value, test for linear trend = 0.049; 
data not shown).
We additionally evaluated the relations 
of serum wet­weight concentrations of DDE, 
DDT, and HCB, without lipid adjustment 
or lipid standardization, and outcomes, and 
effect estimates were altered negligibly (data 
not shown).
Discussion
Among the 765 women undergoing IVF in 
this study, all had detectable serum levels of 
HCB, DDT, and DDE. Implantation failure 
ORs exceeded 2 for women with serum con­
centrations of HCB in Q4, compared with 
women in the lowest quartile. Previous studies 
within this cohort have shown that serum OC 
concentrations were strongly correlated with 
follicular fluid concentrations (r­values: HCB, 
0.66; p,p´­DDE, 0.92; p,p´­DDT, 0.74) 
(Meeker et al. 2009), and in other popula­
tions OCs were detectable in amniotic fluid 
(Foster et al. 2000), suggesting the possibility 
of direct gamete and embryo exposure.
We are not aware of another study that 
describes the association between clinically 
observed implantation failure and exposure to 
HCB; therefore, it will be critical that further 
studies by other investigators replicate this 
finding. However, a non human primate study 
demonstrated that HCB exposure induced a 
dose­dependent suppression of luteal serum 
progesterone (Foster et al. 1992). Suppressed 
luteal progesterone may increase the likeli­
hood of implantation failure due to reduced 
Table 1. Characteristics of all women undergoing IVF eligible for inclusion in the analytic population 
(n = 765) and women included in the final model (n = 720).
Characteristic
All 
(765 women, 827 cycles)
Included 
(720 women, 774 cycles)
Age (years) 35.9 ± 4.21 35.4 ± 4.20
BMI (kg/m2) 24.2 ± 5.09 24.2 ± 5.12
Caucasian 693 (90.6) 651 (90.4)
Cigarette smoking status 
Current smoker 50 (7) 40 (6)
Past smoker 223 (29) 214 (30)
Previous live birth 181 (24) 171 (24)
Total gonadotropins (mIU)a 34.4 ± 18 34.4 ± 18
Down-regulation stimulation protocola 604 (73) 569 (74)
ICSIa 259 (31) 245 (32)
No. of embryos transferreda 3.15 ± 1.33 3.16 ± 1.33
Serum lipids (mg/g) 5.12 ± 1.13 5.22 ± 1.17
Infertility diagnosisb 
Tubal factor 143 (19) 129 (18)
Ovulatory dysfunction 99 (13) 92 (13)
Male factor 267 (35) 251 (35)
Unexplained 256 (34) 248 (34)
IVF outcomea 
Failed implantation 229 (28) 209 (27)
Chemical pregnancy 177 (21) 161 (21)
Spontaneous abortion 124 (15) 120 (16)
Other (ectopic/stillbirth/molar pregnancy) 11 (1) 10 (1)
Live birth 286 (35) 274 (35)
Values are mean ± SD or n (%). 
aCycle-level data. bPrimary infertility diagnosis.
Table 2. Distribution of serum HCB, p,p´-DDE, and total DDT concentrations among 765 women under-
going IVF.
OC GM Minimum Q1 (mean) Median Q3 (mean) Maximum
Wet weight (ng/g serum)
HCB 0.088 0.005 0.066 0.087 0.114 2.31
p,p´-DDE 1.09 0.007 0.659 1.04 1.75 30.6
Total DDTa 1.22 0.020 0.741 1.12 1.88 31.8
Lipid standardized (ng/g lipid)
HCB 18 3.39 13.3 17.5 23.0 426
p,p´-DDE 226 26.1 132 210 362 6,627
Total DDTa 251 31.7 148 233 390 6,977
aTotal DDT includes the sum of p,p´-DDT, o,p´-DDT, p,p´-DDE, and o,p´-DDE.
HCB, DDT, DDE, and IVF
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endometrial maturation or of early pregnancy 
loss from inadequately low levels of proges­
terone production (Jones and Wentz 1976). 
Other studies demonstrated that HCB expo­
sure was associated with degenerative changes 
in ovarian structure, including germ cell 
destruction in rhesus monkeys (Iatropoulos 
et al. 1976) and primordial germ cell loss in 
cynomolgus monkeys (Jarrell et al. 1993), 
suggesting other potential mechanism of 
impaired reproductive outcome.
Our study did not find a statistically 
significant association between HCB and 
chemical pregnancy or spontaneous abortion. 
However, exposure to HCB­contaminated 
foods in Turkey between 1955 and 1957 
resulted in detectable HCB in serum drawn 
40 years later. In that population, higher HCB 
levels were associated with a self­ reported his­
tory of spontaneous abortion (Jarrell et al. 
1998). Furthermore, time to pregnancy, a 
possible surrogate marker for implantation 
failure, was not assessed in that study.
In the present study, we also found no 
significant association between serum DDT/
DDE and implantation failure, chemical preg­
nancy, or early pregnancy loss. However, we 
did observe a non significant OR of 1.6 for 
any of the three early pregnancy failure types 
among cycles in p,p´­DDE Q4 compared with 
those in Q1.
One study that evaluated serum DDE lev­
els among 1,717 women and assessed past preg­
nancy outcomes via survey found a significant 
adjusted OR of 1.4 (95% CI: 1.1, 1.6) for fetal 
loss in women per 60­µg/L increase of serum 
DDE (Longnecker et al. 2005). The primary 
limitation of that study was the retrospective 
design in which current serum DDE concen­
trations were associated with past fetal loss. 
Another study that followed newly married 
female textile workers in China also found an 
association between serum total DDT (range, 
5.5–113.3 ng/g serum; median, 27.9 ng/g) and 
subsequent early fetal loss, defined as < 6 weeks 
of gestation as measured through decline 
in urinary hCG (Venners et al. 2005). In a 
smaller study with 99 women undergoing their 
first cycle of IVF, no statistically significant 
relationships between serum and follicular con­
centrations of DDT/DDE and oocyte num­
ber, quality, fertilization rates, or pregnancy 
rates were reported, although serum DDT/
DDE concentrations were higher than in our 
study population. The authors suggested that 
some “statistically suspicious” associations were 
observed; however, ORs, CIs, and p­values 
were not given (Jirsova et al. 2010).
One limitation of the present study is 
that the study population consisted of cou­
ples undergoing IVF. It is unknown whether 
infertile couples respond differently to OC 
exposure relative to fertile couples or women 
with untested fertility. Therefore, although 
Table 3. Adjusted ORsa and 95% CIs for cycle outcomes in relation to serum HCB quartiles among 
720 women undergoing IVF.
Models with HCB concentrations 
standardized by serum lipids (g)




Women Cycles Events OR (95% CI) Women Cycles Events OR (95% CI)
Failed implantation
Q1 189 204 38 Referent 197 209 41 Referent
Q2 181 203 48 1.33 (0.82, 2.15) 188 208 55 1.71 (1.03, 2.82)
Q3 192 204 65 1.81 (1.11, 2.95) 191 208 67 2.30 (1.39, 3.81)
Q4 191 203 75 2.31 (1.42, 3.77) 195 208 71 2.32 (1.38, 3.90)
ptrend < 0.001 0.001
Chemical pregnancy
Q1 189 204 47 Referent 197 209 42 Referent
Q2 181 203 41 0.86 (0.52, 1.44) 188 208 45 1.14 (0.70, 1.91)
Q3 192 204 45 1.30 (0.77, 2.18) 191 208 44 1.43 (0.84, 2.44)
Q4 191 203 41 1.07 (0.62, 1.85) 195 208 46 1.35 (0.78, 2.34)
ptrend 0.49 0.20
Spontaneous abortion
Q1 189 204 32 Referent 197 209 35 Referent
Q2 181 203 34 1.07 (0.59, 1.95) 188 208 32 1.06 (0.57, 1.93)
Q3 192 204 31 1.40 (0.74, 2.66) 191 208 28 1.12 (0.59, 2.13)
Q4 191 203 25 1.08 (0.55, 2.10) 195 208 29 1.23 (0.64, 2.35)
ptrend 0.59 0.52
Early pregnancy failure
Q1 189 204 118 Referent 197 209 119 Referent
Q2 181 203 123 1.11 (0.73, 1.70) 188 208 134 1.38 (0.89, 2.13)
Q3 192 204 147 1.96 (1.22, 3.14) 191 208 144 1.91 (1.20, 3.02)
Q4 191 203 145 1.81 (1.11, 2.96) 195 208 149 1.98 (1.19, 3.28)
ptrend 0.003 0.003
aJoint models for multiple outcomes and multiple cycles per woman were adjusted for serum lipids, study site, study 
phase, race/ethnicity, previous live birth, maternal age, BMI, smoking status, ampules of gonadotropins, protocol, ICSI, 
number of embryos transferred, and primary infertility diagnosis. bWet-weight serum (ng/g serum) measurements were 
used to assign quartiles, followed by lipid adjustment (g lipid/g serum) using lipid as a covariate in the model; 66% of the 
cycles had a lipid-adjusted HCB value in the same quartile as the lipid-standardized HCB value.
Table 4. Adjusted ORsa and 95% CIs for cycle outcomes in relation to serum p,p´-DDE quartiles among 
720 women undergoing IVF.
Outcome/DDE quartile
Models with p,p´-DDE concentrations 
standardized by serum lipids (g)
Models adjusted for serum lipids (ng/g) as 
a covariateb
n n
Women Cycles Events OR (95% CI) Women Cycles Events OR (95% CI)
Failed implantation
Q1 188 204 48 Referent 195 209 54 Referent
Q2 184 203 52 0.98 (0.61, 1.56) 187 208 56 1.16 (0.72, 1.86)
Q3 187 204 65 1.17 (0.73, 1.86) 193 208 61 1.12 (0.70, 1.81)
Q4 194 203 61 1.14 (0.70, 1.83) 196 208 63 1.19 (0.73, 1.94)
ptrend 0.29 0.56
Chemical pregnancy
Q1 188 204 43 Referent 195 209 43 Referent
Q2 184 203 45 1.19 (0.72, 1.98) 187 208 40 1.09 (0.64, 1.87)
Q3 187 204 41 1.16 (0.68, 1.96) 193 208 45 1.14 (0.67, 1.81)
Q4 194 203 45 1.19 (0.70, 2.03) 196 208 49 1.36 (0.78, 1.94)
ptrend 0.56 0.30
Spontaneous abortion
Q1 188 204 30 Referent 195 209 30 Referent
Q2 184 203 32 1.21 (0.66, 2.22) 187 208 32 1.02 (0.55, 1.93)
Q3 187 204 22 0.62 (0.33, 1.18) 193 208 24 0.67 (0.34, 1.30)
Q4 194 203 38 1.40 (0.74, 2.65) 196 208 38 1.33 (0.69, 2.56)
ptrend 0.67 0.70
Early pregnancy failure
Q1 188 204 124 Referent 195 209 130 Referent
Q2 184 203 131 1.16 (0.76, 1.79) 187 208 129 1.08 (0.70, 1.65)
Q3 187 204 129 0.96 (0.62, 1.47) 193 208 133 1.03 (0.67, 1.59)
Q4 194 203 149 1.52 (0.94, 2.44) 196 208 154 1.61 (0.98, 2.63)
ptrend 0.12 0.09
aJoint models for multiple outcomes and multiple cycles per woman were adjusted for serum lipids, study site, study 
phase, race/ethnicity, previous live birth, maternal age, BMI, smoking status, ampules of gonadotropins, protocol, ICSI, 
number of embryos transferred, and primary infertility diagnosis. bWet-weight serum (ng/g serum) measurements were 
used to assign quartiles, followed by lipid adjustment (g lipid/g serum) using lipid as a covariate in the model. 
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the results of this study are internally valid, it 
is unclear whether the associations of between 
HCB or DDE/DDT and early pregnancy out­
comes would differ among women who have 
never experienced infertility. However, in the 
spontaneous conception setting, it would not 
be possible to evaluate the association between 
these OC exposures and implantation failure 
because it is currently unobservable. The sec­
ond limitation is that serum concentrations 
were available only for females and not their 
male partners. However, exposures to certain 
ubiquitous chemicals have been shown to be 
correlated within couples undergoing IVF 
(Mahalingaiah et al. 2008). Certain predictors 
of serum OC concentration were not available 
for this analysis, such as past breast­feeding 
history and country of origin. However, most 
patients were likely to be of American origin; 
other known predictors of persistent pesti­
cide exposure were included in our models, 
 including age and smoking.
Finally, the serum sample from which OC 
concentration and lipid content were quanti­
fied was not a fasting sample. Although both 
lipid content and serum wet weight of OC 
increase after a meal, they do not increase pro­
portionally. Furthermore, the method chosen 
for lipid correction does affect the final cor­
rected concentration. The equation used in our 
study to calculate total lipids was chosen from 
those suggested by Phillips et al. (1989) and 
accounts for total cholesterol and triglycerides 
but does not diminish the differences between 
fasting and non fasting lipid profiles. However, 
when lipids are accounted for, there are data to 
suggest that there still is a high degree of corre­
lation between a fasting and non fasting serum 
sample (0.96) (Longnecker et al. 1996).
Our study had a number of strengths. The 
prospective cohort from which this nested 
case–control study population was drawn 
employed risk set sampling that allowed for 
collection of questionnaire data and biological 
samples before the cycle outcome and tem­
porally close to the clinically and biologically 
relevant outcomes of interest. In addition, our 
analyses applied advanced statistical methodol­
ogy that validly accommodated inclusion of 
data from multiple cycle outcomes per woman 
and time­varying exposures and potential con­
founders. The assessment of early reproductive 
end points observable only during the IVF 
process allows for insight into critical points in 
early pregnancy.
The HCB levels in the study population 
were close to but generally lower than those 
of the adult female U.S. population (CDC 
2009). Additionally, levels of DDT/DDE 
observed within Q4 among the women in 
our study population were lower than those 
of the general populations of many Asian and 
African countries where DDT is still in use 
(CDC 2009; Perry et al. 2006; Rusiecki et al. 
2005). Therefore, relations observed within 
our study population may be estimating the 
association of these OCs only within the lower 
tail of the international exposure distribution. 
Further studies in the general U.S. population 
and in countries with high pesticide burdens 
are needed.
Conclusion
We found significantly greater odds of implan­
tation failure in relation to serum HCB levels. 
Persistent organic chemicals, despite banned use 
within the United States, may have an adverse 
impact on conception and pregnancy progres­
sion. Couple­based exposure assessment and 
study of the adverse effects on gametes, endo­
metrium, and embryo development are needed 
so that these risks can be better understood.
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